KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Total Non-Current Liabilities: 2014-2016

Historic Total Non-Current Liabilities for Xenon Pharmaceuticals (XENE) over the last 3 years, with Dec 2016 value amounting to $3.5 million.

  • Xenon Pharmaceuticals' Total Non-Current Liabilities was N/A to $45.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.2 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2016, which is 26.38% up from last year.
  • According to the latest figures from FY2016, Xenon Pharmaceuticals' Total Non-Current Liabilities is $3.5 million, which was up 26.38% from $2.8 million recorded in FY2015.
  • Over the past 5 years, Xenon Pharmaceuticals' Total Non-Current Liabilities peaked at $14.4 million during FY2014, and registered a low of $2.8 million during FY2015.
  • For the 3-year period, Xenon Pharmaceuticals' Total Non-Current Liabilities averaged around $6.9 million, with its median value being $3.5 million (2016).
  • In the last 5 years, Xenon Pharmaceuticals' Total Non-Current Liabilities slumped by 80.74% in 2015 and then rose by 26.38% in 2016.
  • Over the past 3 years, Xenon Pharmaceuticals' Total Non-Current Liabilities (Yearly) stood at $14.4 million in 2014, then slumped by 80.74% to $2.8 million in 2015, then rose by 26.38% to $3.5 million in 2016.